It will be interesting to hear this.
Prof Bart Meuris, principal investigator of DurAVR™ first in human study, has been accepted to present the initial results for the first time at this year's upcoming 34th #EACTS Annual Meeting. This will be a big meeting and a fantastic platform to discuss our results.
Ann: Operations update, page-68
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.20 |
Change
-0.800(5.71%) |
Mkt cap ! $279.0M | |||
| Open | High | Low | Value | Volume |
| $14.20 | $14.41 | $13.11 | $539.6K | 40.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2249 | $13.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.88 | 125 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |